Cooper Companies, Inc. (The) Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/6/2026)
| Balance Sheet | Total Assets | 12,394,800,000.00 | ROE | 66.47 % |
| Balance Sheet | Total Equity | 8,238,900,000.00 | ROA | 3.02 % |
| Cashflow | Capital Expenditures | -362,400,000.00 | P/FCF | 25.31 |
| Cashflow | Free Cash Flow | 433,700,000.00 | – | – |
| Cashflow | Operating Cash Flow | 796,100,000.00 | P/CF | 13.79 |
| Income | Earnings per Share (diluted) | 1.87 | Div. Yield | – |
| Income | Net Income | 374,900,000.00 | P/E | 29.35 |
| Income | Shares Outstanding | 198,100,000.00 | P/B | 1.33 |
| Income | Total Revenue | 4,092,400,000.00 | P/S | 2.68 |
Ratios calculated on: 10/14/2026
Company Description
The Cooper Companies, Inc. (Cooper, we or the Company), a Delaware corporation organized in 1980, is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life CompanyTM.. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision is a global manufacturer providing products for contact lens wearers. CooperVision develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues; with a broad collection of spherical, toric and multifocal contact lenses. CooperVision's contact lenses are offered in a variety of materials including silicone hydrogel Aquaform® technology and phosphorylcholine technology (PC) Technology™. CooperVision primarily manufactures its products at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and the United States. CooperVision distributes products out of its facilities in the United States, the United Kingdom, Belgium and various smaller international distribution facilities.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.coopercos.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more